Oncology Institute (TOI) Gross Margin (2021 - 2026)

Oncology Institute (TOI) has reported Gross Margin for 6 consecutive years, with 94.39% the latest figure, recorded in Q1 2026.

• Gross Margin for Q1 2026 came in at 94.39%, up 2447.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 86.28% (down 1183.0% YoY), and the FY2025 annual result was 56.13%, down 4354.0% from the prior year.
• Gross Margin was 94.39% for Q1 2026 at Oncology Institute, up from 53.13% in the prior quarter.
• Over five years, Gross Margin peaked at 210.1% in Q4 2024 and troughed at 43.62% in Q4 2023.
• Average Gross Margin over 5 years is 75.09%, with a median of 59.87% recorded in 2024.
• Year-over-year, Gross Margin surged 16648 bps in 2024 and tumbled 15697 bps in 2025.
• Over 5 years, Gross Margin stood at 99.83% in 2022, then tumbled by 56 bps to 43.62% in 2023, then soared by 382 bps to 210.1% in 2024, then sank by 75 bps to 53.13% in 2025, then surged by 78 bps to 94.39% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 94.39% in Q1 2026, 53.13% in Q4 2025, and 100.0% in Q3 2025.